Jake Micallef

432 total citations
13 papers, 236 citations indexed

About

Jake Micallef is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jake Micallef has authored 13 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jake Micallef's work include Cancer Genomics and Diagnostics (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (3 papers). Jake Micallef is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (3 papers). Jake Micallef collaborates with scholars based in Denmark, Sweden and Italy. Jake Micallef's co-authors include Mariëlle Herzog, Mark Eccleston, Bodil Andersson, Roland Andersson, Monika Bauden, Daniel Ansari, Hans Jørgen Nielsen, Ib Jarle Christensen, Jean‐François Rahier and Laurence Faugeras and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Oncotarget.

In The Last Decade

Jake Micallef

12 papers receiving 219 citations

Peers

Jake Micallef

ONCOL

PRM

PFM

Ariana Rostami Canada

Gloria Leszinski Germany

Clare Bartos United Kingdom

Jitka Hausnerová Czechia

Luca Paglialunga Italy

Rhafaela Lima Causin Brazil

Moito Iijima Japan

Floriana Camarda Italy

Carl Barrett United States

Shi‐Xun Lu China

Ariana Rostami Canada

Jake Micallef

120 ×0.8

141 ×1.2

49 ×0.6

ONCOL

49 ×1.0

PRM

28 ×0.8

PFM

Citations per year, relative to Jake Micallef Jake Micallef (= 1×) peers Ariana Rostami

Countries citing papers authored by Jake Micallef

Since Specialization

Citations

This map shows the geographic impact of Jake Micallef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Micallef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Micallef more than expected).

Fields of papers citing papers by Jake Micallef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Micallef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Micallef. The network helps show where Jake Micallef may publish in the future.

Co-authorship network of co-authors of Jake Micallef

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Micallef. A scholar is included among the top collaborators of Jake Micallef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Micallef. Jake Micallef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Micallef, Jake, et al.. (2022). HTA141 Does NICE’s New Severity Modifier Capture the Value of Treatments for Long-Term Progressive Diseases? A Retrospective Analysis of Past Appraisals in Multiple Sclerosis. Value in Health. 25(12). S324–S324.

Micallef, Jake, et al.. (2022). HTA151 The NICE Cost Comparison Pathway - How Much Evidence Is Required to Meet the Criteria?. Value in Health. 25(12). S326–S326. 1 indexed citations

Micallef, Jake, et al.. (2022). MSR63 When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning. Value in Health. 25(7). S530–S530. 1 indexed citations

Andrews, Henry Russell, Hardev Pandha, Elena Jachetti, et al.. (2020). The Open University's First One-Day Symposium on Treatment-Emergent Neuroendocrine Prostate Cancer. Future Oncology. 16(6). 147–149. 2 indexed citations

Terrell, Jason, et al.. (2020). Circulating nucleosomes in hematological malignancy.. Journal of Clinical Oncology. 38(15_suppl). e20078–e20078. 2 indexed citations

Herzog, Mariëlle, Mark Eccleston, Jake Micallef, et al.. (2017). Validation of Nu.Q™ colorectal cancer screening triage test to identify FIT positive individuals at low risk of screen relevant neoplasia. Annals of Oncology. 28. iii146–iii146. 2 indexed citations

Rahier, Jean‐François, Laurence Faugeras, Mariëlle Herzog, et al.. (2017). Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer. Clinical Epigenetics. 9(1). 53–53. 66 indexed citations

Christensen, Ib Jarle, et al.. (2017). Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer. Oncotarget. 9(12). 10247–10258. 29 indexed citations

Nielsen, Hans Jørgen, Ib Jarle Christensen, Berit Andersen, et al.. (2017). Serological biomarkers in triage of FIT-positive subjects?. Scandinavian Journal of Gastroenterology. 52(6-7). 742–744. 11 indexed citations

10.

Herzog, Mariëlle, et al.. (2016). A novel epigenetic immunoassay approach to profiling circulating nucleosomes for CRC detection. Annals of Oncology. 27. vi561–vi561. 1 indexed citations

11.

Herzog, Mariëlle, Jake Micallef, Orhan Bulut, et al.. (2016). Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3. Scandinavian Journal of Clinical and Laboratory Investigation. 76(6). 448–453. 9 indexed citations

12.

Bauden, Monika, Daniel Ansari, Mariëlle Herzog, et al.. (2015). Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer. Clinical Epigenetics. 7(1). 106–106. 81 indexed citations

13.

Holdenrieder, Stefan, Jens Standop, Mariëlle Herzog, et al.. (2014). Novel serum nucleosomics biomarkers for the detection of colorectal cancer.. PubMed. 34(5). 2357–62. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact